Clopidogrel [klopidogrel]
- Terms
-
clopidogreli besilas
clopidogreli hydrochloridum
clopidogreli sulfas
Iscover
klopidogrel-besilát
klopidogrel-hydrochlorid
klopidogrel-sulfát
Plavix
-
Clopidogrel Besilate
Clopidogrel Besylate
Clopidogrel Bisulfate
Clopidogrel Hydrochloride
Clopidogrel Napadisilate
Clopidogrel Sandoz
Clopidogrel-Mepha
Clopidogrel, (+)(S)-isomer
Iscover
PCR 4099
PCR-4099
Plavix
SC 25989C
SC 25990C
SR 25989
A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.
- DUI
- D000077144 MeSH Browser
- CUI
- M0155432
- CAS
- Methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate
- History note
- 2019 (1988)
- Public note
- 2019; CLOPIDOGREL was indexed under TICLOPIDINE 1988-2018
Allowable subheadings
- AD
- administration & dosage 22
- AE
- adverse effects 13
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 1
- CL
- classification
- EC
- economics 1
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 2
- PD
- pharmacology 7
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 34
- TO
- toxicity
- UR
- urine